1255 related articles for article (PubMed ID: 8672851)
21. High affinity interaction of integrin alpha4beta1 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) enhances migration of human melanoma cells across activated endothelial cell layers.
Klemke M; Weschenfelder T; Konstandin MH; Samstag Y
J Cell Physiol; 2007 Aug; 212(2):368-74. PubMed ID: 17352405
[TBL] [Abstract][Full Text] [Related]
22. Integrins alpha5beta1, alphavbeta1, and alphavbeta6 collaborate in squamous carcinoma cell spreading and migration on fibronectin.
Koivisto L; Grenman R; Heino J; Larjava H
Exp Cell Res; 2000 Feb; 255(1):10-7. PubMed ID: 10666329
[TBL] [Abstract][Full Text] [Related]
23. Modulation of LIF expression in human melanoma cells by oncostatin M.
Heymann D; Blanchard F; Raher S; De Groote D; Godard A
Immunol Lett; 1995 Jun; 46(3):245-51. PubMed ID: 7590943
[TBL] [Abstract][Full Text] [Related]
24. Alpha-V/beta-3 and alpha-V/beta-5 integrin distribution in neoplastic kidney.
Rabb H; Barroso-Vicens E; Adams R; Pow-Sang J; Ramirez G
Am J Nephrol; 1996; 16(5):402-8. PubMed ID: 8886177
[TBL] [Abstract][Full Text] [Related]
25. Expression and ligand-binding function of the integrin alpha 4 beta 1 (VLA-4) on neural-crest-derived tumor cell lines.
Bednarczyk JL; McIntyre BW
Clin Exp Metastasis; 1992 Jul; 10(4):281-90. PubMed ID: 1535575
[TBL] [Abstract][Full Text] [Related]
26. Unraveling the extracellular matrix-tumor cell interactions to aid better targeted therapies for neuroblastoma.
Burgos-Panadero R; El Moukhtari SH; Noguera I; Rodríguez-Nogales C; Martín-Vañó S; Vicente-Munuera P; Cañete A; Navarro S; Blanco-Prieto MJ; Noguera R
Int J Pharm; 2021 Oct; 608():121058. PubMed ID: 34461172
[TBL] [Abstract][Full Text] [Related]
27. X-ray microscopic visualization of specific labeling of adhesive molecule CD36 and cytoadherence by Plasmodium falciparum infected erythrocytes.
Yeung J; Brown JT; Nair A; Meites E; Coppel RL; Mohandas N; Meyer-Ilse W; Magowan C
Res Commun Mol Pathol Pharmacol; 1998 Mar; 99(3):245-58. PubMed ID: 9591321
[TBL] [Abstract][Full Text] [Related]
28. Enhanced melanogenesis induced by tyrosinase gene-transfer increases boron-uptake and killing effect of boron neutron capture therapy for amelanotic melanoma.
Tsuboi T; Kondoh H; Hiratsuka J; Mishima Y
Pigment Cell Res; 1998 Oct; 11(5):275-82. PubMed ID: 9877098
[TBL] [Abstract][Full Text] [Related]
29. Evaluation on serum 2'-5'oligoadenylate synthetase (2'-5'oligoAS) and beta 2 microglobulin (B2M) in patients with nodal metastases from cutaneous malignant melanoma treated with rIFN-alpha 2A.
Martinetti A; Seregni E; Belli F; Mazzocchi A; Agresti R; Cascinelli N; Greco M; Bombardieri E
Anticancer Res; 1998; 18(3B):2027-30. PubMed ID: 9677461
[TBL] [Abstract][Full Text] [Related]
30. The use of recombinant adeno-associated viral vectors for the transduction of epithelial tumor cells.
Hoerer M; Bogedain C; Scheer U; Heberger C; Steyrer S; Burger A; Maass G
Int J Immunopharmacol; 1997; 19(9-10):473-9. PubMed ID: 9637341
[TBL] [Abstract][Full Text] [Related]
31. Role of protein kinase C and phosphatases in 12(S)-HETE-induced tumor cell cytoskeletal reorganization.
Tang DG; Honn KV
Adv Exp Med Biol; 1997; 400A():349-61. PubMed ID: 9547577
[TBL] [Abstract][Full Text] [Related]
32. Results of complete lymph node dissection in 83 melanoma patients with positive sentinel nodes.
Joseph E; Brobeil A; Glass F; Glass J; Messina J; DeConti R; Cruse CW; Rapaport DP; Berman C; Fenske N; Reintgen DS
Ann Surg Oncol; 1998 Mar; 5(2):119-25. PubMed ID: 9527264
[TBL] [Abstract][Full Text] [Related]
33. T helper 1 cytokine mRNA is increased in spontaneously regressing primary melanomas.
Lowes MA; Bishop GA; Crotty K; Barnetson RS; Halliday GM
J Invest Dermatol; 1997 Jun; 108(6):914-9. PubMed ID: 9182821
[TBL] [Abstract][Full Text] [Related]
34. [123I-alpha-methyltyrosine scintigraphy in malignant melanoma].
Steinert H; Böni R; Huch-Böni RA; Capaul R; von Schulthess GK; Westera G
Nuklearmedizin; 1997 Mar; 36(2):36-41. PubMed ID: 9148271
[TBL] [Abstract][Full Text] [Related]
35. Efficacy, safety, and risk-benefit analysis of adjuvant interferon alfa-2b in melanoma.
Kirkwood JM; Resnick GD; Cole BF
Semin Oncol; 1997 Feb; 24(1 Suppl 4):S16-23. PubMed ID: 9122729
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of EGF receptor is associated with spontaneous metastases of a human melanoma cell line in nude mice.
Huang TS; Rauth S; Das Gupta TK
Anticancer Res; 1996; 16(6B):3557-63. PubMed ID: 9042221
[TBL] [Abstract][Full Text] [Related]
37. Selective growth of human melanoma cells in the brain parenchyma of nude mice.
Fujimaki T; Price JE; Fan D; Bucana CD; Itoh K; Kirino T; Fidler IJ
Melanoma Res; 1996 Oct; 6(5):363-71. PubMed ID: 8908596
[TBL] [Abstract][Full Text] [Related]
38. Allogeneic murine melanoma cell vaccine: a model for the development of human allogeneic cancer vaccine.
Knight BC; Souberbielle BE; Rizzardi GP; Ball SE; Dalgleish AG
Melanoma Res; 1996 Aug; 6(4):299-306. PubMed ID: 8873049
[TBL] [Abstract][Full Text] [Related]
39. Conventional isolated hyperthermic antiblastic perfusion in the treatment of recurrent limb melanoma.
Decian F; Mondini G; Demarchi R; Muzio G; Sementa A; Bocchio MM; Spirito C; Simoni G; Civalleri D
Anticancer Res; 1996; 16(4A):2017-24. PubMed ID: 8712736
[TBL] [Abstract][Full Text] [Related]
40. A brief spiritual beliefs inventory for use in quality of life research in life-threatening illness.
Holland JC; Kash KM; Passik S; Gronert MK; Sison A; Lederberg M; Russak SM; Baider L; Fox B
Psychooncology; 1998; 7(6):460-9. PubMed ID: 9885087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
